Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neo-MASCT in primary hepatocellular carcinoma
NCT03067493Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jul 2017
- Primary completion
- Mar 2023
- Modality
- Whole Cell Cancer Vaccines, Allogeneic CAR-T, TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of Neo-MASCT in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
Neo-MASCT
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03067493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03067493.